Immunome Announces Additional $4.3 Million Award By Dod Following Positive Preclinical Testing Results On Covid-19 Variants Of Concern
Round Type
Grant
BothellBiotechnologyHealth CareMedicalTherapeuticsDescription
Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell discovery engine platform to discover and develop first-in-class antibody therapeutics, today announced a $4.3 million increase awarded by the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency (DHA), for the continued development of an antibody cocktail (IMM-BCP-01) to combat SARS-CoV-2 and its variants. The additional capital comes less than a year after an initial DOD award of $13.3 million, bringing the total commitment to Immunome to $17.6 million
Quick answer
Immunome Inc. raised an undisclosed amount in a Grant round, dated May 20, 2021. Immunome Inc. is based in Bothell, Washington, United States.
- How much did Immunome Inc. raise?
- Immunome Inc. raised an undisclosed amount in a Grant round on May 20, 2021.
- What does Immunome Inc. do?
- Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies.
- Where is Immunome Inc. based and how big is it?
- Immunome Inc. is based in Bothell, Washington, United States. Fundz records about 283 employees.
- Who are the decision-makers at Immunome Inc?
- Fundz holds 2 contacts at Immunome Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Immunome Inc. that raised within 45 days of this round, from Fundz verified event records.
- OncoNano Medicine raised $50M (Series B) on June 17, 2021.
- MAIA Biotechnology raised $8M (Funding Round) on May 19, 2021.
- RetinalGeniX Technologies raised $45K (Pre-Seed) on July 1, 2021.
- Julier Medical raised an undisclosed amount on June 30, 2021.
- Synaptogenix raised $12M on June 29, 2021.
- Biorez, Inc. raised $3.9M (Seed) on June 25, 2021.
Who to call at Immunome Inc., and when
A new round usually means Immunome Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Immunome Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Immunome Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Immunome Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Immunome Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Immunome Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.